Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Vertex Ventures HC (VVHC) is a venture capital firm dedicated to the healthcare industry, particularly in life science innovation. Founded to support the development of novel therapeutic approaches, VVHC operates from its offices in San Francisco and Boston. The firm has established itself as a key player in the healthcare investment space, focusing on various sectors such as biopharmaceuticals, medical devices, and digital health.
As of now, Vertex Ventures HC manages assets totaling $400 million and has a diverse portfolio that spans multiple stages of investment, from pre-seed to Series C. The firm has a global investment strategy, targeting promising companies in North America, Europe, and Asia. This broad geographic focus allows VVHC to tap into a wide range of innovative healthcare solutions and technologies.
Over the years, Vertex Ventures HC has achieved notable milestones, including investments in groundbreaking companies that address significant medical challenges. Their commitment to advancing healthcare innovation is evident in their strategic partnerships and collaborations within the life sciences sector.
Vertex Ventures HC invests across all stages of company development, from early preclinical-stage ventures to those at the commercial stage. The firm specifically targets areas with significant unmet medical needs, aiming to create value for both shareholders and patients. Their investment strategy is characterized by a global perspective, focusing on promising healthcare companies in the U.S., Europe, Asia, and beyond.
Investment sectors include biotech, healthcare, and digital health, with a strong emphasis on life sciences innovation. VVHC seeks to partner with companies that are developing novel therapeutic approaches and technologies that can significantly impact patient care. The firm is particularly interested in biopharmaceuticals, medical devices, and digital health solutions that address critical healthcare challenges.
In terms of check sizes, Vertex Ventures HC is flexible, investing in pre-seed, seed, seed-plus, Series A, Series B, and Series C rounds. This diverse approach allows them to support companies at various stages of their growth, ensuring that they can provide the necessary capital and resources to help these companies succeed.
Vertex Ventures HC boasts a notable portfolio of companies that are making significant strides in the healthcare sector. Key portfolio companies include:
This diverse array of companies highlights VVHC's commitment to investing in innovative solutions that address significant healthcare challenges. Each of these companies is positioned to make a meaningful impact in their respective fields, showcasing the firm's strategic focus on life sciences and healthcare innovation.
Lori Hu, MBA - Managing Director. Lori has extensive experience in venture capital and healthcare investments, having previously worked at leading firms in the industry.
Christine Brennan, PhD - Managing Director. Christine brings a strong background in life sciences and has led numerous successful investments in healthcare startups.
Amanda Chen, PhD - Vice President. Amanda specializes in biotech investments and has a track record of identifying promising healthcare innovations.
Dave Van Meter, MBA - Venture Partner. Dave has a wealth of experience in operational roles within healthcare companies, providing valuable insights to portfolio firms.
George Golumbeski - Venture Advisor. George has a strong background in biopharmaceuticals and offers strategic guidance to VVHC's portfolio companies.
Faheem Hasnain - Venture Advisor. Faheem is known for his expertise in healthcare investments and has played a key role in several successful exits.
Tom Daniel - Venture Advisor. Tom brings extensive experience in drug development and commercialization, enhancing VVHC's investment strategy.
To pitch Vertex Ventures HC, founders should send an email to hello@vertexventureshc.com. The pitch deck should include key information such as the business model, market analysis, competitive landscape, and team qualifications. A clear and concise presentation is preferred.
Response times can vary, but founders can generally expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In recent months, Vertex Ventures HC has made several notable investments in the healthcare sector, including backing companies like Boundless Bio and Redona Therapeutics. These investments align with the firm's focus on addressing significant unmet medical needs through innovative therapeutic approaches.
Additionally, the firm has expanded its portfolio to include companies developing cutting-edge technologies in biopharmaceuticals and medical devices. This activity underscores VVHC's commitment to advancing healthcare innovation and supporting startups that are poised to make a meaningful impact.
What are Vertex Ventures HC's investment criteria?
Vertex Ventures HC invests in companies at all stages of development within the healthcare sector, focusing on significant unmet medical needs. They look for innovative solutions in biopharmaceuticals, medical devices, and digital health.
How can I pitch to Vertex Ventures HC?
Founders can reach out via email at hello@vertexventureshc.com. It's advisable to include a detailed pitch deck outlining the business model, market opportunity, and team background.
What makes Vertex Ventures HC different from other VC firms?
VVHC emphasizes a global investment strategy and targets companies that address critical healthcare challenges. Their focus on life sciences innovation sets them apart in the venture capital landscape.
What is the geographic scope of Vertex Ventures HC's investments?
The firm invests globally, with a particular focus on North America, Europe, and Asia. This broad geographic reach allows them to identify and support promising healthcare innovations worldwide.
What is the typical check size for investments?
Vertex Ventures HC invests across various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. Check sizes vary depending on the stage and specific needs of the company.
What kind of post-investment involvement can founders expect?
VVHC typically engages with portfolio companies through board involvement and operational support, providing strategic insights and resources to help them grow and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.